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In 2010, Scotland became the first country to implement a national naloxone programme (NNP) 
which aimed to make naloxone available to anyone at risk of opioid overdose [1]. Take-home 
naloxone (THN) supplies are typically made from community addiction and harm reduction services 
including community pharmacy. Further details on the key components of the NNP are available in 
detail elsewhere [1,2,3,4]. As well as community-based supplies, THN is made available to prisoners-
on-release. Prisoners were identified as a key target population for the NNP given their elevated risk 
of drug-related death in the first few weeks following liberation [5,6]. On average, 7,800 individuals 
are incarcerated within Scotland’s prisons daily [7] and a third of those entering prison test positive 
for opiates at reception [8]. 
There is limited published evidence in relation to the structure or indeed impact of prison-based 
THN programmes. This commentary provides an overview of the first author’s experiences of 
coordinating the NNP in Scotland within the Scottish Prison Service with a particular focus on: 
delivery model; challenges; and developments.  
Delivery model 
Prisoners who test positive for opiates at reception, or advise prison staff of recent/current opiate 
use (including opiate replacement therapy), are made aware of the NNP and asked if they would like 
to receive training in the use of naloxone during their sentence. Those expressing an interest at this 
stage are followed up by NHS healthcare staff based within the prison, normally within 6 weeks prior 
to their liberation date, but training can be completed at any time during their sentence. Those who 
decline to be involved at this stage are re-approached at later dates in their sentence by NHS 
healthcare staff and encouraged to participate. It is recognised that the point at which prisoners are 
initially entering prison is not an optimal time to be considering health interventions that will be 
3 
 
utilised post-release and where other competing issues related to their impending loss of liberty may 
take priority and the THN message could potentially be ‘lost’ [9].  
For those prisoners who agree to participate, NHS healthcare staff will typically deliver a naloxone 
training session for them close to their release date [either from prison or court], often in 
combination with other pre-release programmes.  
Implementation challenges 
Training 
Initially, NNP training within the prison service was designed to be delivered in a group setting 
facilitated by two members of staff (one clinical). This model presented a variety of problems. Firstly, 
from an operational perspective, organising key personnel (i.e. trainers and participants) to be all in 
the one place/time proved to be problematic due to the prison regime in addition to the presence of 
competing priorities for prisoners (e.g. attending gym sessions, work places and visits) [10]. Prison 
officers were required to escort prisoners to wherever the training was taking place, however this 
was not always facilitated as prisoners were often reportedly unwilling to attend the sessions. 
Availability of staff also impacted on delivery of naloxone training sessions as a result of the 
requirement for sessions to be co-facilitated.  
Secondly, from an individual perspective, group sessions were not always suitable in the prison 
environment, particularly with the subject under discussion having the potential to be emotive for 
those involved; indeed the majority of people who use drugs will have had personal experience of 
overdose or experienced the loss of friends and loved ones through overdose, often recently 
[11,12,13]. Having to practice basic life support may also have been intimidating for some in a group 
setting, in particular those with no previous training, knowledge or skills in the subject area.  
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Due to the high numbers of refusals to attend groups, and the challenging operational factors 
identified above, prisons have recently moved to replicate the community NNP training model of 
brief interventions, delivered in a one-to-one format over 10-15 minutes and requiring only one 
member of staff to facilitate. The transition from mainly group-based training sessions to one-to-one 
brief interventions is in line with emerging evidence which suggests that brief education is sufficient 
to improve individual abilities in recognising and managing overdose [14].  
Reception  
Although the processes may vary slightly between establishments, generally once a prisoner has 
been trained nursing staff are required to label a naloxone kit and deliver this to the reception area 
where the prison officers have responsibility for transferring the kit into the prisoners valuable 
property.  The prisoner then collects their property on release.  
During the early implementation of the NNP, difficulties emerged in relation to ensuring naloxone 
kits were placed within the prisoners’ valuable packs [10]. This issue reportedly stemmed from a lack 
of awareness among prison officers regarding what the medication was and highlighted a major 
need to ensure that prison officers were better informed about naloxone in order to implement a 
more streamline process at the point of release.  
The limited awareness among prison officers regarding naloxone at the outset of the programme 
[and its knock-on effects in relation to prisoners attending training and/or receiving their kits on 
release] is not unique to Scotland and has been reported elsewhere [9]. Crucial to overcoming these 
issues has been dedicated training initiatives focussed on the prison officers themselves. Often 
acting as gatekeepers to in-house training programmes, the role of prison officers is vital in helping 
to normalise take-home naloxone within the prison environment and in breaking down accessibility 





To address apparent low engagement with the NNP across Health Boards, a community naloxone 
peer education initiative was initiated by Scottish Drugs Forum (SDF) in 2012 [15]. This was 
subsequently extended to the prison service, with work progressing in four prison establishments 
aimed at involving peers more centrally in the delivery of the NNP. To date, across the four 
establishments, a total of 63 male and 6 female prisoners have completed the SDF naloxone peer 
education training. Training is delivered over two days with the support of the prison service and 
subsequent monthly follow-up sessions are offered to the peer trainers and staff involved in the 
programme.  
Generally prison staff will identify prisoners who may be suitable to become naloxone peer 
educators, however peers who have low supervision status i.e. privileges which allow them wider 
access to other prisoners to deliver the training and to implement the programme effectively.  For 
example, in one establishment, peers introduced a section on naloxone in the prison induction 
programme that was already peer delivered. This awareness session is therefore delivered to all new 
prisoners in that establishment who attend induction. At this stage, peers will gather a list of those 
interested in completing the training and they will be offered the opportunity to attend either a 
group or a one-to-one training session delivered by peers themselves. Once they have completed 
their training, peers pass on the names and prisoner numbers to the NHS healthcare staff who will 
then ensure that a naloxone kit is provided within their valuable property on release.  
The peer education approach potentially enhances the NNP greatly due to the credibility of peers, 
the message(s) they are able to get across and the collaborative working between prisoners and 
staff.  As well as having the appropriate supervision status, the length of stay of prisoners is 
important when selecting peer trainers in the prison environment. Ideally long-term prisoners will be 
involved to avoid a requirement to constantly re-train new peers. The relocation of prisoners is also 
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challenging as the establishment they move to may not be equipped to support them in their peer-
education role. 
Use of peers to deliver information and education on overdose and naloxone within has been 
recommended previously by both prison staff [10] and people who use drugs [16]. However, the 
impact of this peer-led innovation is not yet known, but is important in terms of future research.  
Naloxone availability for prison officers 
A new development for the Scottish Prison Service is an agreement that naloxone will be made 
available in an emergency for prison officers to use when they arrive first on the scene. Prior to this, 
health professionals would be required to intervene; in the absence of available medical staff (e.g. 
overnight) an ambulance would typically be called which can often take time to arrive.  This new 
initiative has already been introduced in one prison establishment with further roll out across the 
prison estate planned. Providing prison officers with the skills to intervene with naloxone in an 
overdose emergency could save vital time and create an additional window to allow the emergency 
medical services to attend and provide specialist care if required. These developments mirror 
attempts in other territories to increase availability and accessibility of naloxone beyond small 
numbers of specialist staff within prisons. For example, in New York state, a wide standing order has 
been approved which enables nursing staff to administer naloxone to anyone within correctional 
facilities without first obtaining a physician order. Prior to this development, nurses required 
individual doctor orders when an overdose was suspected [17]. 
Conclusion  
The NNP in Scotland marked an important milestone in drug policy. Evidence is now emerging to 
demonstrate the reach and impact of the programme, but also in relation to the barriers it has faced 
and the innovation and partnership working required to overcome them. Implementation across 
Scottish Prisons has posed particular challenges linked to both operational issues within prison 
7 
 
establishments and individual factors affecting staff delivering, and prisoners engaging, with the 
programme. This commentary has described how the development of the programme in prisons has 
adapted to these challenges to a point where a largely consistent model is in place and where 
prisoners-on-release are reaping the benefits in terms of reduced opioid-related mortality.  
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